Chiromics is prospecting new molecular space
through creation of Accessible Complexity: unique and diverse drug-like small molecule collections that are stereochemically complex generated by Chiromics proprietary technology.


Chiromics has developed proprietary libraries available for purchase. These libraries incorporate state-of-the-art MacMillan group technology to produce accessibly complex medicinal cores.


Chiromics can utilize its in-house affinity selection mass spectrometry (ASMS) expertise for screening of client targets against our compound collections for hit identification. Chiromics can provide rapid resysnthesis of putative ligands deriving from in-house ASMS in either racemic or enantiopure form.

Custom synthesis:

In collaboration with clients, Chiromics can perform synthesis of highly customized proprietary libraries. These can be derived from the clients' internal drug discovery efforts or Chiromics' compound screening collections.

Website by Princeton Internet Group, Inc. (PING)